NFE2L2 and glioblastoma: In conclusion, these combined molecular effects suggest that CBD, administered at low doses to glioblastoma cells, could cause oxidative stress, leading to mitochondrial damage that would be repaired through the activation of autophagy and the increase in NRF2 levels, inducing a state of quiescence in the glioblastoma.